These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 29644882

  • 1. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X, Feng S, Chi Y, Liu J, Sun K, Guo C, Wu Z.
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
    Gazzano E, Buondonno I, Marengo A, Rolando B, Chegaev K, Kopecka J, Saponara S, Sorge M, Hattinger CM, Gasco A, Fruttero R, Brancaccio M, Serra M, Stella B, Fattal E, Arpicco S, Riganti C.
    Cancer Lett; 2019 Aug 01; 456():29-39. PubMed ID: 31047947
    [Abstract] [Full Text] [Related]

  • 6. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 7. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR, Paliwal R, Pal HC, Saxena AK, Sharma PR, Gupta PN, Agrawal GP, Vyas SP.
    Mol Pharm; 2012 Jan 01; 9(1):176-86. PubMed ID: 22091702
    [Abstract] [Full Text] [Related]

  • 8. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S, Wu ZX, Zhao Z, Liu J, Sun K, Guo C, Wang H, Wu Z.
    ACS Appl Mater Interfaces; 2019 Feb 20; 11(7):7357-7368. PubMed ID: 30682240
    [Abstract] [Full Text] [Related]

  • 9. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y, Zhang J, Meng F, Deng C, Cheng R, Feijen J, Zhong Z.
    J Control Release; 2016 Jul 10; 233():29-38. PubMed ID: 27178807
    [Abstract] [Full Text] [Related]

  • 10. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.
    Haghiralsadat F, Amoabediny G, Naderinezhad S, Nazmi K, De Boer JP, Zandieh-Doulabi B, Forouzanfar T, Helder MN.
    Pharm Res; 2017 Dec 07; 34(12):2891-2900. PubMed ID: 29110283
    [Abstract] [Full Text] [Related]

  • 13. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
    Zou Y, Meng F, Deng C, Zhong Z.
    J Control Release; 2016 Oct 10; 239():149-58. PubMed ID: 27569664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M, Sun H, Meng F, Cheng R, Zhang J, Deng C, Zhong Z.
    J Control Release; 2018 Feb 28; 272():107-113. PubMed ID: 29355618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery.
    Zou A, Chen Y, Huo M, Wang J, Zhang Y, Zhou J, Zhang Q.
    J Pharm Sci; 2013 Jan 28; 102(1):126-35. PubMed ID: 23073894
    [Abstract] [Full Text] [Related]

  • 19. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS, Silva JO, Monteiro LOF, Leite EA, Cassali GD, Rubello D, Cardoso VN, Ferreira LAM, Oliveira MC, de Barros ALB.
    Biomed Pharmacother; 2016 Dec 28; 84():252-257. PubMed ID: 27664949
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.